Corrigendum: Tetrac and NDAT induce anti-proliferation via integrin αvβ3 in colorectal cancers with different K-RAS status (Frontiers in Endocrinology (2019) 10:130 DOI:10.3389/fendo.2019.00130)

Yu Tang Chin, Zong Rong He, Chi Long Chen, Hsiao Ching Chu, Yih Ho, Po Yu Su, Yu Chen S.H. Yang, Kuan Wang, Ya Jung Shih, Yi Ru Chen, Jens Z. Pedersen, Sandra Incerpi, André Wendindondé Nana, Heng Yuan Tang, Hung Yun Lin, Shaker A. Mousa, Paul J. Davis, Jacqueline Whang-Peng

Research output: Contribution to journalComment/debate

1 Citation (Scopus)


In the original article, we neglected to include the funder “E-Da Hospital, EDAHP107018” to Z-RH. The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Original languageEnglish
Article number241
JournalFrontiers in Endocrinology
Issue numberAPR
Publication statusPublished - Jan 1 2019



  • Anticancer
  • Colorectal cancer cells
  • Integrin αvβ3
  • NDAT
  • Perfusion bellows cell culture system
  • PhosphoERK1/2
  • Tetrac

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism

Cite this